39 results
8-K
EX-99.2
NVRO
Nevro Corp
7 Jan 19
Results of Operations and Financial Condition
9:10am
LEADERSHIP THROUGH INNOVATION J.P. Morgan 37th Annual Healthcare Conference January 2019 Exhibit 99.2
SPECIAL NOTE REGARDING FORWARD-LOOKING … to launch a high frequency SCS system Continued clinical leadership Began enrollment of two RCTs: PDN and NSRBP Momentum in RCT enrollment 1st DBS
8-K
EX-99.1
NVRO
Nevro Corp
20 Mar 19
Nevro Announces New CEO, Board Appointments and Agreement with Broadfin Capital
8:46am
New Leadership
REDWOOD CITY, Calif., March 19, 2019 – Nevro Corp. (NYSE: NVRO) (“Nevro”), a global medical device company that is providing … , effective immediately, and accepted the resignation of Ali Behbahani as a director. The leadership appointments follow constructive engagement
8-K
EX-99.1
NVRO
Nevro Corp
3 Dec 20
Nevro Announces Director Appointment
7:12am
technology, now being applied to important growth markets, and its stellar leadership team. Learning that Nevro’s products have been life changing … in molecular biology and biochemistry, Ms. Siegel held executive leadership roles at Amersham, DuPont, and Bio-Rad. She currently serves on the boards
8-K
EX-99.1
NVRO
Nevro Corp
19 Apr 23
Results of Operations and Financial Condition
5:07pm
, since April 2022. Under Kevin’s leadership, this group of businesses delivered above-market revenue growth rates, achieving about $2.9 billion … , I would like to thank Keith for his leadership and commitment to the company over the last four years as President and CEO,” said Michael DeMane
PRE 14A
j5vvaunjs9txworz
29 Mar 19
Preliminary proxy
4:53pm
8-K
EX-99.1
dckjs9j9jwregdbc
18 Dec 19
Nevro Appoints Karen N. Prange to the Company’s Board of Directors
7:15am
8-K
EX-99.1
hel1ge
2 Mar 15
Nevro Appoints Dr. Brad Vale to its Board of Directors
12:00am
8-K
EX-99.1
gsswulxy
31 Aug 21
Nevro Announces Director Appointment
4:17pm
S-1
EX-10.13
l3hcuay080yyw
3 Oct 14
IPO registration
12:00am
8-K
EX-99.1
yi6 3uicfx9r4r
7 May 24
Nevro Reports First-Quarter 2024 Financial Results
4:11pm
8-K
v2etmolk83 pggeh7
9 May 24
Departure of Directors or Certain Officers
4:52pm
8-K
EX-99.1
lcum5ifcpnwx051
9 May 19
Nevro Reports First Quarter 2019 Financial Results
4:18pm